We are live on ! Find out more
HOOK icon

HOOKIPA Pharma

Delisted

HOOK was delisted on the 7th of August, 2025.

54 hedge funds and large institutions have $38.3M invested in HOOKIPA Pharma in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.54% less ownership

Funds ownership: 57.92% → 55.38% (-2.5%)

7% less funds holding

Funds holding: 58 → 54 (-4)

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

30% less call options, than puts

Call options by funds: $72K | Put options by funds: $103K

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

61% less capital inflows, than outflows

Capital inflows: $844K | Capital outflows: $2.17M

Holders
54
Holders Change
-4
Holders Change %
-6.9%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
14
Closed
10
Calls
$72​K
Puts
$103​K
Net Calls
-⁠$31​K
Net Calls Change
-⁠$83​K

HOOK Hedge Fund Activity: Q3 2022 in Review

54 of the 5,834 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q3 2022, worth a combined $38.3M — down 20% from $48M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of HOOK and 6 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 11 added.

The largest buyer was Bridgeway Capital Management, adding an estimated $190K. The largest seller was Fidelity Investments, cutting an estimated $980K.

  • 54 institutional investors held HOOKIPA Pharma (HOOK) as of Q3 2022, down from 58 in Q2 2022.
  • Funds reported $38.3M of HOOKIPA Pharma stock for Q3 2022, down 20% quarter-over-quarter.
  • 6 funds opened new HOOKIPA Pharma positions in Q3 2022 and 10 closed out, a net change of -4 holders.
  • The largest HOOKIPA Pharma buyer in Q3 2022 was Bridgeway Capital Management, an estimated $190K added.
  • The largest HOOKIPA Pharma seller in Q3 2022 was Fidelity Investments, an estimated $980K sold.

Based on aggregated 13F filings for Q3 2022.